Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer by Daisy Mak et al.
Mak et al. Radiation Oncology 2012, 7:139
http://www.ro-journal.com/content/7/1/139RESEARCH Open AccessSeminal vesicle interfraction displacement and
margins in image guided radiotherapy for
prostate cancer
Daisy Mak1*, Suki Gill1, Roxby Paul2, Alison Stillie1, Annette Haworth2, Tomas Kron2, Jim Cramb2, Kellie Knight3,
Jessica Thomas1, Gillian Duchesne1,4 and Farshad Foroudi1,4Abstract
Background: To analyze interfraction motion of seminal vesicles (SV), and its motion relative to rectal and
bladder filling.
Methods and Materials: SV and prostate were contoured on 771 daily computed tomography “on rails” scans
from 24 prostate cancer patients undergoing radiotherapy. Random and systematic errors for SV centroid
displacement were measured relative to the prostate centroid. Margins required for complete geometric coverage
of SV were determined using isotropic expansion of reference contours. SV motion relative to rectum and bladder
was determined.
Results: Systematic error for the SV was 1.9 mm left-right (LR), 2.9 mm anterior-posterior (AP) and 3.6 mm
superior-inferior (SI). Random error was 1.4 mm (LR), 2.7 mm (AP) and 2.1 mm (SI). 10 mm margins covered the
entire left SV and right SV on at least 90% of fractions in 50% and 33% of patients and 15 mm margins covered
88% and 79% respectively. SV AP movement correlated with movement of the most posterior point of the bladder
(mean R2 = 0.46, SD = 0.24) and rectal area (mean R2 = 0.38, SD = 0.21).
Conclusions: Considerable interfraction displacement of SV was observed in this cohort of patients. Bladder and
rectal parameters correlated with SV movement.
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In prostate cancer radiotherapy, proximal seminal vesi-
cles (SV) are usually included in the clinical target vol-
ume (CTV) in intermediate to high risk prostate cancer.
Bayman et al. conducted a review of prostatectomy
series and revealed that the risk of SV invasion in inter-
mediate risk patients is between 13 and 22% [1]. As a re-
sult, recommendations were made to encompass SV in
patients with at least one risk factor of PSA >10, Gleason
Score ≥7, T stage >2A, or percentage of positive biopsy
>50%. Due to its proximity to rectum and bladder, SV
inclusion may result in an increased rectal or bladder* Correspondence: daisy.mak@petermac.org
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reproduction in any medium, provided the ortoxicity [2]. Methods which reduce SV CTV to planning
target volume (PTV) margins may reduce side effects
from radiotherapy.
Image guided radiotherapy (IGRT) is increasingly
being used in the treatment of prostate cancer [3]. In
IGRT, the prostate gland is localized before each fraction
of treatment to allow for the correction of prostate dis-
placement. This is usually performed without localization
of the SV because SV are usually not visible on planar
imaging and can be difficult to identify on cone beam
computed tomography (CT).
Internal organ movement of the prostate is well docu-
mented in the literature [4]. SV motion has been rela-
tively less well described, and is summarized in Table 1.
We aimed to use daily CT on rails images to i) quantify
the inter-fraction SV displacement in relation to the cen-
troid of prostate during a course of radiotherapy for. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Studies analysing seminal vesicle motion and margins
Authors Movements
LR/AP/SI* (mm)
Margins Localisation† Method for margins Deformation Patients Scans
per patient
Current work Centre of volume:
Systematic 1.9/2.9/3.6.
Random 1.4/2.7/2.1
Geometric method approx 15 mm
(whole SV and inf 2.5 cm).
Van Herk Formula approx 10 mm.
Prostate centroid Geometrical expansion of
reference SV contours, and
Van Herk Formula
Yes 24 32
Frank et al. [7] Centre of volume:
Systematic 1.9/7.3/4.5.
Random 0.4/1.2/0.6
≥ 10 mm 10 mm covers SV
AP variation in 86% of treatments
Pubic symphysis Geometrical No 15 24
AHerne et al. [8] N/A 5 mm cover both SVs in 56.2% of
fractions,10 mm cover 95.5%,
15 mm cover all
Prostate fiiducial markers Geometrical - margin to





approx 3.0 (1.7 in LR)
Approx 9–10 mm (illustrative). Prostate fiducial markers Van Herk Formula (illustrative) Yes 21 4




Liang et al. [16] Maximize overlap of SV volume.
Systematic 1.1/2.9/2.2.
Random 1.2/2.4/1.9
Minimum margins 4.5 mm (IMRT) Prostate (maximize overlap of
3D volume)
Dose (deformable registration) Yes 24 16
O’Daniel et al.[17] N/A Study compared alignment technique
and found 5 mm margins give a
minimum of 92% of dose to
SV using IMRT
Prostate centroid Minimum dose in any fraction Yes 10 24
Meijer et al. [18] N/A 8 mm (inferior 2 cm of SV) (IMRT) Prostate fiducial markers Dose (deformable registration) Yes 30 8
Smitsmans
et al. [19]
Image based registration of
central (sup/inf) part of SV
Systematic 1.6/2.8/–
Random 2.0/3.1/–
4.6 mm LR 7.6 mm AP Prostate fiducial markers Van Herk Formula No 13 23
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with translations (but not rotations), ii) assess geometry-
based (rather than dose-based) margins required to
completely cover the SV for any percentage of fractions,
using isotropic expansion of reference contours to allow
for both movement and deformation independent of
treatment technique and iii) evaluate correlations be-
tween SV motion and changes in the rectum and blad-
der, two structures which may be easier to see than the
SV themselves using soft tissue IGRT.
Methods and materials
Patient demographics
With human research ethical board approval, CT data-
sets of 24 consecutive patients treated radically for pros-
tate cancer with daily pre-treatment CT on rails imaging
were evaluated. Patient enrollment and treatment setup
have been documented in our previous publication [5].
A total of 771 scans were obtained between the 24
patients (median 32 scans each, range 18 – 36). Median
age was 72 years (range 55 – 78 years). Eight of these
patients were staged T1, 13 had T2 disease and 3 had
T3 disease. Eleven patients had PSA <10 ng/ml, 8 had
PSA 10 – 20 ng/ml and 5 had PSA >20 ng/ml. Gleason
score was ≤ 6 in 11 patients, 9 had Gleason score 7 and
4 had Gleason score ≥8.
Imaging and treatment
Patients were treated to a total dose of 74 Gy in 37
fractions, 2 Gy per fraction, 5 days per week on a Sie-
mens PRIMATOM (Siemens OCS, Concord, USA) lin-
ear accelerator. Patients were instructed to empty their
bladder and rectum one hour before treatment and to
drink 750 ml of water. They were immobilized supine
on a carbon fiber couch top with foot stocks and knee
support. Initial setup was by alignment of three skin
tattoos to lasers. Setup was verified by a pre-treatment
CT scan prior to each fraction (from a Siemens
SOMATOM diagnostic CT scanner, using the same
couch top and mounted on rails). CT slices were
reconstructed with 5 mm thickness and spacing. If the
rectal diameter was over 4 cm on the pre-treatment
CT, the patient was taken off the bed and asked to
empty their rectum before re-CT and treatment. The
first pre-treatment CT for each patient was used as the
reference image for movement analysis as this was
closer in time to the rest of treatment than the plan-
ning scan.
Volume delineation
CT on rail images were imported into XiOTM CMS
(Elekta Ltd, Crawley, UK). Prostate, bladder and rectum
were contoured by a single investigator (KK). Two inves-
tigators (DM, AS) contoured SV, with all the images inone patient study set contoured by the same investiga-
tor. At the start of the study both investigators con-
toured test cases and compared results to ensure their
work was consistent.
Displacement analysis
The contours were exported as DICOM structure sets.
Software was written in C++ using the dicomlib toolkit
(available at http://code.google.com/p/dicomlib/) to read
the structure sets and calculate volumes and centroid
positions using the original contours. Centres of
volumes (centroids) were calculated for the entire SV,
the inferior 2.5 cm and the tip (most superior slice) of
the SV. The prostate centroid was used as the origin on
each fraction, with the other centroid positions (i.e. SV
movements) being reported relative to this point. Trans-
lational movement was measured, but not rotational
displacement.
Assessment of margins
SV margins were assessed using two methods (i) the van
Herk formula (margin = 2.5 x systematic error + 0.7 x
random error) [6], and (ii) geometrically based on iso-
tropic expansion of SV contours. For the second
method, software was written to interpolate the refer-
ence SV contours onto a 1 mm x 1 mm x 1 mm grid.
The left and right SV for each patient were considered
separately. All voxels inside the contours were marked
to form a volume. An isotropic 3D margin was applied
to this reference SV volume (CTV) using convolution
for each margin size. The margin size was increased in
1 mm increments. For each margin size, the appropriate
(left or right) SV contours from each daily treatment
scan were overlaid onto the voxel grid, after alignment
of the prostate centroids, to check if the points forming
the contours would fit inside the grown reference SV
volume. If any part was outside by more than 1 mm,
coverage was considered as inadequate. This process
was repeated with the inferior 2.5 cm of each SV
considered.
Correlation of SV movement with organ volume
In order to obtain the average rectal area and volume,
two separate methods were used in this study. All
volumes were calculated by the software mentioned
above.
Method 1
Method 1 was conducted to see if the volume of rectum
adjacent to the SV correlated with day to day SV dis-
placement since the rectum is more easily localized than
SV on pretreatment imaging such as cone beam CT.
Only the section of rectum adjacent to SV on the refer-
ence scan was used for analysis. To assess the rectal
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in the same CT slice positions (relative to the prostate
centroid) as on the reference scan was examined. Total
rectal volume was measured, and area was calculated by
dividing the volume by the slice width and the number
of slices which contained rectum. If there was significant
rectal movement during treatment, the number of CT
slices containing rectum in the predefined CT slice posi-
tions could be smaller. In fact, there was significant rec-
tal movement in two patients where there was no
rectum seen in the correlating CT slices on treatment,
and hence, method 2 was used to calculate rectal volume
and area.
Method 2
Rectal volume and area were measured from the level of
the prostate centroid to the recto-sigmoid junction. This
method will be valid for all patients, however, correla-
tions with SV movement was expected to be weaker as a
longer length of rectum was considered, where a signifi-
cant portion of rectum was not adjacent to SV.
Statistical analysis
Mean and standard deviation (SD) were used to describe
the variation in volumes of relevant organs during the
course of treatment. For the SV movement analysis, both
systematic and random errors were calculated. Linear re-
gression analyses were used to explore the correlation
(R2) of SV displacements in relation to contralateral SV
displacement, bladder volume, motion of the most pos-
terior point of the bladder, rectal area and rectal volume.
Results
Random and systematic error for SV displacements
Systematic and random displacement of SV centroids
and margins from the van Herk formula are given inTable 2 Systematic and random errors for displacement of th















LR 1.5 1.3 1.3 3.3
AP 2.7 3.1 2.7 3.9
SI 3.1 3.4 3.5 4.0
Random
error (mm) (σ)
LR 1.3 1.3 1.3 3.3
AP 2.7 2.9 2.9 4.0
SI 2.1 2.1 2.1 3.5
van Herk
Margin (mm)
LR 4.7 4.2 4.2
AP 8.6 9.8 8.8
SI 9.2 10.0 10.2
*Data from 13 LSV or 15 RSV, as the remaining SVs were shorter than 2.5 cm on the
†Combined data for both SVs, all patients.Table 2. Differences between LSV and RSV were not sta-
tistically significant.
Geometric margin based on isotropic SV expansion
A margin of 15.6 mm was required to cover the whole
left SV for 90% of fractions for 90% of the entire pa-
tient cohort. For the right SV, a margin of 16.5 mm
was required. For the inferior 2.5 cm of left and right
SV, margins of 13.6 mm and 16.3 mm were required.
(Figure 1, Figure 2). The mean margins required for
each patient to cover 90% of the fractions were as fol-
low: entire LSV 11.3 mm (SD 3.4 mm), inferior 2.5 cm
LSV 10.3 mm (SD 2.5 mm), entire RSV 12.3 mm (SD
3.5 mm), and inferior 2.5 cm RSV 11.2 mm (SD
3.3 mm).
There were 13 patients with LSV and 15 patients with
RSV which were longer than 2.5 cm on the reference
scan. In this subgroup, the mean margins for each pa-
tient to cover 90% of their fractions were: entire LSV
12.1 mm (SD 3.6 mm), inferior 2.5 cm LSV 10.8 mm
(SD 2.4 mm), entire RSV 12.0 mm (SD 2.8 mm), and in-
ferior 2.5 cm RSV 11.0 mm (SD 2.9 mm).
Figure 3 demonstrates the relationship between geo-
metrical margins and systematic error (the amount by
which the position of the SV centroid on the reference
scan, relative to the prostate centroid, was not typical for
the rest of the treatment, for example due to rectal gas
in the reference scan.)
Variation in volumes
The mean superior-inferior (SI) length of SV on all CT
images was 2.7 cm (range 1 to 4.5 cm with CT slice spa-
cing of 0.5 cm) for the left SV and 2.8 cm (range 1 to
5 cm) for the right SV. In those patients (13 LSV, 15
RSV) where LSV or RSV was longer than 2.5 cm on the


















2.1 1.6 1.7 4.4 1.9 1.9 4.2
3.0 3.2 3.6 4.2 2.9 2.9 4.0
4.1 3.3 3.1 5.8 3.6 3.5 5.0
1.5 1.6 1.5 3.9 1.4 1.4 3.6
2.7 2.7 2.8 4.1 2.7 2.8 4.1
2.1 2.3 2.2 3.5 2.1 2.1 3.5
6.3 5.1 5.3 5.7 5.7
9.4 9.9 11.0 9.1 9.2
11.7 9.9 9.3 10.5 10.2
reference scan.
Figure 2 Percentage of patients where the entire or the inferior 2.5 cm of SV is within the PTV on at least 90% of the fractions. Data
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Figure 1 a) Margins required to cover the entire left seminal vesicle. Results for all 24 patients were plotted individually. b) Margins required
to cover the inferior 2.5 cm portion of left seminal vesicle, c) entire right seminal vesicle and d) inferior 2.5 cm portion of right seminal vesicle.
Same line colour has been used for each individual patients in Figure 1a – d.
Mak et al. Radiation Oncology 2012, 7:139 Page 5 of 9
http://www.ro-journal.com/content/7/1/139









0 2 4 6 8 10 12 14
















LSV RSV Linear (LSV) Linear (RSV)
Figure 3 Relationship between the geometrical margin to cover SV and systematic error (average movement of the seminal vesicle
centroid from its position in the reference scan, expressed as the length of the 3D vector). Three fractions were excluded as outliers which
give margins that fit approximately 90% of all fractions.
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SV and prostate volumes on the reference scan were
8.3 cm3, 8.8 cm3 and 32 cm3 respectively. The SD of vol-
ume variations during treatment for LSV was 1.28 cm3,
RSV 1.22 cm3, and prostate 4.58 cm3.
The mean bladder volume of all reference scans was
258 cm3. After some smoothing of day to day volume
variation (median SD 62 cm3), three patients had a sig-
nificant trend of bladder volume as treatment pro-
gressed (R2 > 0.2). For these three patients, bladder
volume was reduced by 1.2%, 1.4% and 0.9% per fraction
on average.
The mean rectal area (method 1) of all reference scans
was 14.1 cm2 with a median day to day variation (SD) of
3.7 cm2. After smoothing, four patients had a significant
trend as treatment progressed (defined as R2 > 0.2 and
change per day greater than 0.15 cm2). The rectal area
for these four patients was reduced by 1.0%, 1.9%, 1.7%
























Figure 4 Correlation of SV AP movement with movement of the mosSV displacement in relation to bladder, rectum and
contralateral SV
Correlation of contralateral SV movements was seen in
the SI (R2 = 0.72) and anterior-posterior (AP) (R2 = 0.44)
directions, but not in the left-right (LR) direction.
There was a weak association between AP SV motion
and bladder volume. Out of twenty four, six left SV and
seven right SV had a correlation (R2) ≥ 0.2. However, a
strong correlation was seen between AP movement of
SV and the movement of the most posterior point of the
bladder as shown in Figure 4. On a per patient basis the
mean correlation (R2) for the left SV was 0.46 with a SD
of 0.23. For the right SV, the mean correlation (R2) was
0.46 with a SD of 0.24.
Correlation between SV movement and rectal area and
volume is shown in Figure 5 and Table 3. Weak correla-
tions (mean R2~ 0.2) were observed in the SI and LR
directions. Stronger correlations (mean R2 up to 0.4) were
observed in the AP direction with method 1 showing0.6 0.8 1 1.2
r mm change in most  
f bladder
LSV (each point is one patient)
RSV (each point is one patient)
t posterior point of the bladder.
00.9
1
-1.2 -1 -0.8 -0.6 -0.4 -0.2 0
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Figure 5 Correlation of SV AP movement with change in rectal area using Method 1 of rectal area evaluation. Data for both LSV and RSV
for all patients were plotted individually. A negative value on the x axis represents anterior movement of SV as rectal area increases.
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showed a slightly greater correlation than rectal volume
with AP SV movement. Method 1 could not be used for
28/31 fractions of one patient, and 2/34 fractions of a sec-
ond patient, due to the recto-sigmoid junction moving to
a position inferior to SV on the reference scan.
Discussion
This study assessed a large number of scans (median 32
per patient) for a considerable number of patients (24)
and found considerable SV motion relative to the pros-
tate. We looked at a sufficient number of patients to
see some with large systematic errors requiring largerTable 3 Rectal area and volume correlations with SV moveme
Rectal contour using Method 1*





Ant/Post LSV 0.40 0.23 0.37
RSV 0.36 0.19 0.35
Sup/Inf LSV 0.20 0.17 0.22
RSV 0.22 0.17 0.23
Left/Right LSV 0.19 0.19 0.19
RSV 0.18 0.18 0.15
* Rectal contouring methods have been described in the Methods and Materials semargins. Assessing a large number of pre-treatment
CTs enabled us to use actual SV contours for the
movement at each fraction, rather than assuming a
normal distribution.
Table 1 gives an overview of the studies looking at SV
movements and margins required for SV in radiotherapy.
The papers using a dose-based analysis generally find
considerably smaller margins, as do those when the pros-
tate and SV were assessed in combination. Studies using
prostate fiducial markers or the prostate centroid for
localization report reasonably similar movements.
We estimated margins in two ways, using the van
Herk formula, and by considering geometric coveragents
Rectal contour using Method 2*






0.22 0.38 0.24 0.35 0.21
0.16 0.35 0.21 0.33 0.17
0.19 0.21 0.18 0.23 0.19
0.19 0.20 0.16 0.24 0.20
0.19 0.21 0.20 0.17 0.18
0.18 0.20 0.18 0.15 0.17
ction.
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The van Herk formula estimates the probability of distri-
bution of the cumulative dose over a population of
patients, but excludes rotational errors and shape devia-
tions. Our geometric analysis allows for rotation and de-
formation but ignores dose outside of the PTV. Both
methods reported large margins, with the van Herk for-
mula estimates closely approximating findings from
other studies [7,8]. Larger margins of 15.6 mm and
16.5 mm were required to cover the whole left and right
SV for 90% of fractions for 90% of the entire patient co-
hort in this study using the geometrical analysis. These
resultant margins are not recommended for treatment
purposes given the potential toxicities from dose to blad-
der and rectum. Moreover, small excursions of SV out-
side of the PTV have only a limited effect on the
cumulative SV dose, particularly if different parts of SV
are missed on different treatment fractions. Dose outside
of the PTV is likely to be higher for the SV because dose
“fall off” from the superior part of the prostate will con-
tribute to dose to the SV. In addition, there are some
limitations of our study. Although mitigated by the use
of interpolation, our geometric method is limited by the
5 mm thick CT slice spacing, with the greatest limitation
in the estimation of SI margin. As a result, reported
movements of the SV tip will be less accurate than
movements of the whole SV and inferior 2.5 cm portion.
Uncertainty in manual contouring of SV on CT slices
will have led to a slight increase in reported movement
and margins. Combining these effects, margin for SV is
likely to be much smaller than the geometrical margins
reported here. Nevertheless, our data show that move-
ment of SV relative to the prostate is substantial and
should be considered when setting margins for con-
formal treatment techniques where daily setup is to the
prostate, particularly as the dose outside the PTV is likely
to be reduced as radiotherapy technology improves.
This study found that the margin required to cover
the proximal 2.5 cm was only a little smaller than the
margin required to cover the entire SV. Differences of
up to 4 mm in the margin to treat 90% of fractions could
be seen for a few patients but the average difference was
1.2 mm. One might expect that displacement and hence
margins were greater as distance increased from the
prostate centroid. However, in those patients where the
SV were longer than 2.5 cm, it was frequently not very
much larger (mean 3.3 cm for both LSV and RSV). This
may explain why the difference in margin for the entire
SV and proximal 2.5 cm were similar.
The extent of SV inclusion is a clinical judgment often
individualized to the patient depending on the proximity
of rectum and small bowel. Guidelines state however
that either the proximal half [1], the proximal 1–2 cm
[9] or at least the proximal 1 cm of SV should beincluded in the high risk CTV and treated to full dose
[10]. A frequently quoted study from the William Beau-
mont Hospital looked at 81 positive SV from clinically
staged ≤T2c prostate cancer patients who subsequently
underwent prostatectomy [11]. The pattern of SV inva-
sion was contiguous in 86%. Of those SV that were posi-
tive, 47% had SV involvement beyond the proximal 25%
of the SV, 14% had SV involvement beyond the proximal
50%, and 2% were involved beyond the proximal 60%.
However, the question of length of SV requiring inclu-
sion in the radiotherapy CTV is still incompletely
answered. In addition, dose required to treat micro-
scopic disease may be reduced. Further research is
required.
Even with a standardized departmental setup protocol,
we have noted that there can be significant changes in
bladder volume and rectal filling during the course of
radiotherapy for some patients. Bladder volumes in our
study did not have a good correlation with SV displace-
ment, but a strong correlation of SV AP movement with
the position of the most posterior point of the bladder
was observed. Correlations with rectal filling were also
observed in our study, as by Frank et al. [7]. Therefore,
patient education and monitoring of bladder and rectal
parameters are encouraged to detect both random and
particularly systematic movements. Systematic and ran-
dom errors might also be reduced by the use of an
endorectal balloon prior to each treatment to provide
constant rectal volume [12].
In a study from the William Beaumont hospital, adap-
tive margins for prostate and SV were created using a
bounding volume of daily pre-treatment imaging in the
first week, or two weeks, of treatment which improved
efficacy [13]. Supporting this, our data (Figure 1, Figure 3)
show that for many patients margin size is reasonably
consistent between fractions and has a component
related to systematic error. Given the non-uniform SV
movement as noted in this study, asymmetric margins
could be explored in future studies with a smaller margin
in the left-right direction.Conclusion
Considerable interfraction SV displacement was
observed in this cohort of patients with simulated IGRT
targeting the prostate. Future radiotherapy technique de-
sign should not neglect SV motion. Correlation of SV
motion with bladder and rectal parameters is observed.Competing interests
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